Search Results 521-530 of 17886 for monoclonal antibody

1. Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

   Cryosurgery kills cancer cells by freezing them. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

2. Clinical trials - Oncology (Medical)

   Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

3. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies ... Patients who have a history of a severe hypersensitivity reaction to monoclonal antibody or pembrolizumab (MK-3475) ...

4. Small Cell Lung Cancer Clinical Trials - Mayo Clinic Research

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

5. Tislelizumab-jsgr (intravenous route) - Side effects & uses - Mayo Clinic

   Tislelizumab-jsgr is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by ...

6. Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug

   A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...

7. Nasopharyngeal Carcinoma Clinical Trials - Mayo Clinic Research

   Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

8. Testing The Use Of Ado-Trastuzumab Emtansine Compared To The Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) For Recurrent, Metastatic, Or Unresectable HER2-Positive Salivary Gland Cancer - Mayo Clinic

   Trastuzumab emtansine is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called emtansine. Trastuzumab attaches to HER2 positive ...

9. Medical Research & Education - Mayo Clinic News Network

   Monoclonal antibodies: Update on this COVID-19 experimental therapy featured image. COVID-19. Monoclonal antibodies: Update on this COVID-19 experimental ...

10. Vedolizumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Vedolizumab injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is a monoclonal antibody that works on ...